Systemic lupus erythematosus (SLE) disproportionately affects women. Recent work demonstrates that men with Klinefelter's syndrome (47,XXY men) have a similar risk of developing SLE as do women. We present an unusual African-American family with two SLE-affected individuals in which one of the patients with SLE also has Turner's syndrome (46,X,del(X)(q13)). Although not definitive, this family raises interesting questions regarding the function of genes located on the X chromosome in the development of SLE. The paucity of case reports documenting the overlap of SLE with Turner's syndrome while there is an association of male SLE with Klinefelter's syndrome suggests a lower risk of SLE in women with Turner's syndrome. These observations are consistent with a gene dose effect at X with two X chromosomes (46,XX or 47,XXY) conferring higher risk and one X chromosome (46,XY or 45,XO) conferring lower risk of SLE.
Introduction
Systemic lupus erythematosus (SLE) is a chronic and complex autoimmune disease, with both an environmental component and a heritable predisposition. The disease disproportionately affects women (9:1 female to male ratio 1 ) and African-American women in particular (European-American women 1:1000; African-American women 1:250). 2, 3 Recent work indicates that the presence of two X chromosomes (genotypic women 3 and men with Klinefelter's syndrome 4 ] or lack thereof (genotypic men and women with Turner's syndrome) influences individual risk of developing the disease.
Turner's syndrome is a rare chromosomal disorder of women (1:2500 live births) first described in 1938 by Turner 5 and characterized by short stature and the lack of sexual development at puberty due to the partial or complete absence of a second X chromosome. 6 The condition is confirmed through DNA karyotyping and/ or fluorescence in situ hybridization (FISH).
Overlap of these two conditions appears to be rare, with only two cases documented. 7, 8 Although without cohort studies of Turner's syndrome among patients with SLE or of SLE among patients with Turner's syndrome, association can neither be confirmed nor be refuted. Participation of patients with SLE with sex chromosome disorders in genetic studies of lupus may help illuminate the location of lupus-related gene(s) on the X chromosome.
Case report
An African-American family with two members diagnosed with SLE was referred to the Lupus Genetics Studies for possible inclusion in the national Lupus Family Registry and Repository (LFRR) housed at the Oklahoma Medical Research Foundation. Per family and physician report, the younger sibling purported to have SLE also had Turner's syndrome.
At age 17 years, this African-American woman was diagnosed with Turner's syndrome. Symptoms and signs revealed to the Lupus Genetics Studies staff included primary amenorrhea and short stature with a height of 145.8 cm (4 ft 9 1 2 inch, less than fifth percentile). No hormone replacement therapy or human growth hormone therapy was initiated.
After 4 months, the same patient was admitted to the hospital with unintended weight loss (15-20 lbs), depression and chest pain. She had a history of joint pain in her hands and right knee and was found to have rashes on the eyes and behind the ears which two rheumatologists observed and suspected of being discoid lupus. Laboratory tests revealed a positive antinuclear antibody (ANA) and positive anti-double-stranded (ds)DNA. Family history of autoimmune illness included a sister with SLE and another relative with rheumatoid arthritis. The patient was diagnosed with SLE by the treating physician.
Medical record abstraction by the LFRR confirmed classification of SLE according to the American College of Rheumatology 1982 Classification Criteria for SLE as updated in 1997 9,10 in both sisters. Classification criteria for the purported patient with Turner's syndrome included a positive ANA (1:360, nuclear homogeneous pattern), positive anti-(ds)DNA (502, normal o10), positive anti-phospholipid antibody, discoid lesions and pleuritic chest with pleural effusion. Additional Testing demonstrated 46,X,del(X)(q13), a terminal long-arm deletion for one of the two X chromosomes. To localize the deletion, we typed DNA on 1.8 million single nucleotide polymorphisms (SNPs) using the 6.0 GeneChip Array (Affymetrix Inc., Santa Clara, CA, USA). We found that the most centromeric SNP deleted was at position 7 56 95 000 with a detected, that is, undeleted, SNP only 20 bp centromeric. Therefore, the Xist gene, which determines X inactivation and is located near the start of the deletion on Xq13.1, was present. We determined by previously reported methods 11 that the full-length X chromosome in this patient was active in some cells, but because the androgen receptor gene was deleted in the truncated X chromosome an estimation of percent inactivation of each X chromosome could not be made. 11 
Discussion
When casually considered, gender may appear dichotomous and discrete. However, because of a wide range of disorders of sex differentiation (reviewed by MacLaughlin and Donahoe 12 ), biological sex is a continuum. A class of disorders of sex differentiation is those with sex chromosomal abnormalities. The common diseases classified as such include Turner's syndrome (45,XO) and Klinefelter's syndrome (47,XXY). We hypothesize that study of disorders of sex differentiation may shed light upon the gender predilection of SLE.
Study of other X chromosome abnormalities has been illuminating in autoimmune disease. For example, acquired X monosomy in peripheral blood cells has been found in autoimmune thyroid disease, systemic sclerosis and primary biliary cirrhosis, but not in SLE. 13 Skewing of X inactivation has been reported in several women-predominate autoimmune diseases (reviewed by Invernizzi et al. 14 ) , but one study found no skewing in SLE. 15 However, this study also found no skewing in systemic sclerosis, whereas others have found marked X inactivation skewing in this disease. 16 Skewed X chromosome inactivation has not been found in identical twins discordant for SLE. 17 Skewing of X inactivation could not be determined in our patient with SLE and Turner's syndrome because techniques for this determination rely on the androgen receptor gene, which is deleted from the truncated X chromosome in our patient.
Turner's syndrome has been associated with several autoimmune diseases. These include autoimmune thyroid disease and Crohn's disease. Of interest, both these diseases are found among patients with Turner's syndrome with particular X chromosome abnormalities, namely, one normal X chromosome and one X isochromosome with two copies of the long arm of X. 18, 19 However, only the study of autoimmune thyroid disease represents a true cohort study of patients with Turner's syndrome, 19 whereas the work describing Crohn's disease in Turner's syndrome is merely a collection of case reports. 18 The other autoimmune disease that reported data most strongly suggest is found in excess among girls with Turner's syndrome is celiac disease, which can be present in up to 10%. 20, 21 Although a lack of association of Tuner's syndrome and SLE is not certain, the possibility that Turner's syndrome, skewed X inactivation and acquired X monosomy are associated with some but not all autoimmune diseases is intriguing, and potentially highly informative if mechanisms for these differences can be determined. In addition, the relationship of Turner's karyotype to autoimmune disease may be important.
We have found that Klinefelter's syndrome occurs in excess among men with SLE such that 47,XXY Klinefelter's men are at the same risk of SLE as ethnically similar women. 4 In this same study, we found that no woman with SLE had Turner's syndrome. 4 Further, although there are numerous case reports of Klinefelter's men with SLE (4, reviewed by Rovensky 22 ), we find only two previous reports of SLE in women with Turner's syndrome: one confirmed and characterized case 7 and one alleged case. 8 We identified the present family by specifically canvassing our collaborators for patients with both Turner's syndrome and SLE. Thus, these data suggest that Turner's syndrome is certainly not overrepresented among patients with SLE and may in fact be underrepresented, consistent with a gene dose effect for the X chromosome. 4 The previous characterized patient with Turner's syndrome/SLE overlap has 45,X/46,XXq þ mosaicism, or a mosaic short-arm deletion of one X chromosome 7 ( Table 1 ). The present report of Turner's syndrome/SLE overlap documents a partial long-arm deletion of the second X chromosome (46,X,del(X)(q13)) without mosaicism. Genes found on X that escape X inactivation (B15% of X genes (reviewed by Sidhu et al. 23 )) are potential gene dose candidates because normal (46,XX) women have two transcribed and translated copies whereas men have only one active copy. Three potential candidates are CD40LG (Xq26), which is demethylated (that is, not inactivated) and overexpressed in T cells from women with SLE 24 , IRAK1 (Xq28) 25 and MECP2 (Xq28). 26 However, the present reported case of Turner's syndrome/SLE overlap has only one copy of each of these genes due to the Xq13 terminal deletion on 46,X (Figure 1b) . Although many genes are involved in the susceptibility to SLE, further study of individuals with Turner's syndrome/SLE overlap may help illuminate the location of lupus-related gene(s) on the X chromosome, as well as further delineate a gene dose effect. Our data suggest that a gene dose effect could reside on the p arm of X or on the q arm centromeric to q13.1; however, other genes on X for which an allelic difference is important, instead of dose, could still reside on the X chromosome. 
